Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Acid Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel Lewis acid catalyzed cyclization route for azepino[4,5-b]indole intermediates. Offers mild conditions and high scalability for API manufacturing.
Patent CN101220048B details a high-yield ZnCl2 catalyzed route for chiral pinanediol esters, offering significant cost reduction and scalability for pharmaceutical intermediates.
Advanced preparation method for Oxitinib Mesylate intermediates via anhydrous catalysis. Delivers high purity, reduced genotoxic impurities, and scalable manufacturing for global supply chains.
Patent CN104151283A reveals green ionic liquid catalysis for xanthene derivatives. Offers cost reduction in pharmaceutical intermediates manufacturing and scalable supply.
Patent CN114478290A reveals a metal halide catalyzed route for oseltamivir intermediates, offering superior purity and yield without column chromatography for reliable supply chains.
Patent CN110483452A reveals a one-step catalytic method for γ-vinylidene-γ-butenolide. Enhances supply chain reliability and reduces manufacturing complexity for pharmaceutical intermediates.
Patent CN111233931B details a novel Remdesivir synthesis using Lewis acid catalysis. Discover cost-effective, scalable manufacturing solutions for high-purity antiviral intermediates.
Patent CN101607896B reveals a green synthesis route for DA-TMHQ using acidic ionic liquids, offering superior catalyst recyclability and reduced environmental impact for vitamin E production.
Patent CN111808106A discloses a novel acid-catalyzed route for pyrrolo[1,2-a]indoles. This method offers high yields, mild conditions, and significant cost reduction potential for supply chains.
Patent CN116396189A details a novel B(C6F5)3 catalyzed route for high-purity (S)-(+)-1-indanyl isocyanate, offering significant cost reduction and scalable manufacturing for pharmaceutical intermediates.
Novel Lewis acid catalysis improves Rociletinib yield and purity. Reliable pharmaceutical intermediate supplier offering cost-effective scale-up solutions.
Patent CN120794988A reveals efficient chiral phosphoric acid catalysis for high-purity indole derivatives, offering significant supply chain and cost advantages.
Patent CN102241614B details a phosphotungstic acid catalyzed method for N-alkyl amides offering significant supply chain stability and cost reduction advantages.
Novel solvent-free synthesis of indolizine derivatives using Sm(OTf)3 catalyst. Reduces pollution and cost for pharmaceutical intermediates. Reliable supply chain partner.
Discover the novel two-step synthesis of polysubstituted tetrahydrofuran dienoids from patent CN112142694A. Achieve cost reduction in pharmaceutical intermediate manufacturing with high yields.
Patent CN113173951B details a ZrCl4-catalyzed route to phosphorylated dihydropyrimidinones, offering high yields and mild conditions for reliable pharmaceutical intermediate supply.
Patent CN101302195B reveals a solid-acid catalyzed synthesis for 7-Hydroxy-3,4-dihydroquinolone, offering high purity and reduced environmental impact for Aripiprazole manufacturing.
Advanced synthesis of 2-methoxy-4-methylbenzylamine via safe reductive amination. Offers significant cost reduction in fine chemical manufacturing and high purity.
Patent CN107674085B reveals a novel Lewis acid-catalyzed route for 1,5-epoxy-benzazepines, offering significant cost reduction in API manufacturing and enhanced supply chain reliability.
Patent CN108440391A reveals a novel borane-catalyzed route for high-purity pyridine intermediates, offering significant cost reduction and scalable manufacturing for global supply chains.